Corbus Pharmaceuticals Holdings, Inc. — Cash Flow Charts
1 years of history · ending 2024-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-42M
Free Cash Flow
$-42M
Investing Cash Flow
$-121M
Financing Cash Flow
$167M
Capex
$0
Stock-Based Comp
$6M
Debt Issued
—
Debt Repaid
—
D&A
$588K
SBC Allocated Expense
$6M
SBC Unrecognized Cost
$5M